Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Retatrutide is administered as a once-weekly subcutaneous injection of up to 12 mg
In the long term, treated patients survived for longer because of this, than did untreated patients
They use a high-pressure, narrow jet of medication, which is forced through a microscopic orifice
GHK-Cu works through multiple mechanisms to reverse this pattern
Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
